UPDATE 2-Valeant CEO tells U.S. Senate of regret over raising drug prices

WASHINGTON/NEW YORK, April 27 (Reuters) - Activist investor

William Ackman promised U.S. lawmakers on Wednesday that he will

urge the board of Valeant Pharmaceuticals to reduce the

high prices of four life-saving drugs that are now at the heart

of two congressional probes.

Read more